← All stocks

NeuroSense Therapeutics Ltd.

NRSN Net buying

CIK 0001875091 #5177 in the set updated 18 Sep 2026

Bought (120 mo)

$400.00K

out of their own pocket, the only kind of buying there is

Sold (120 mo)

$0.00

$0.00 on a plan · $0.00 straight out of an exercise

Sold at will

$0.00

0 of 0 sales

Net

+$400.00K

+$400.00K against sales at will

By person

4 insiders · 2 transactions

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Ben-Noon Alon

Chief Executive Officer

$200.00K (1)

—

+$200.00K

4,534,233

13.93%

$3.63M

+5.8%

Eisenberg Or

Chief Financial Officer

$200.00K (1)

—

+$200.00K

1,504,050

4.62%

$1.20M

+42.7%

Binder Hagit

General Manager

—

521,806

1.60%

$417.44K

+62.1%

Russek-Blum Niva

Chief Technology Officer

—

467,953

1.44%

$374.36K

+74.6%

Individual transactions

Nothing of that kind in this period.

What was left out

Form 4 filings counted 5

Amendments (4/A) skipped 0

Filings about a different issuer 0

Unreadable filings 0

Joint filings 0

Sales on a Rule 10b5-1 plan 0

Sales straight out of an exercise 0

Sales at will 0

Transactions with no price 0

Shares from compensation/vesting 600,000

History held since 30 Mar 2026